Earnings Outlook For Novavax

Novavax NVAX is gearing up to announce its quarterly earnings on Tuesday, 2024-11-12. Here's a quick overview of what investors should know before the release.

Analysts are estimating that Novavax will report an earnings per share (EPS) of $-0.87.

Anticipation surrounds Novavax's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.

New investors should understand that while earnings performance is important, market reactions are often driven by guidance.

Overview of Past Earnings

The company's EPS missed by $0.37 in the last quarter, leading to a 0.68% drop in the share price on the following day.

Here's a look at Novavax's past performance and the resulting price change:

Tracking Novavax's Stock Performance

Shares of Novavax were trading at $8.91 as of November 08. Over the last 52-week period, shares are up 45.59%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release.

To track all earnings releases for Novavax visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.